Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy

Conditions

• Arthritis
• Psoriatic

Interventions

• DRUG: adalimumab
• DRUG: placebo for adalimumab

Sponsor

Abbott